Salidroside ameliorates cerebral ischemic injury and regulates the glutamate metabolism pathway in astrocytes
Background and AimSalidroside (SA) is the main active component of Rhodiola rosea L., with potential in treating cardiovascular and cerebrovascular diseases and cerebral ischemia. However, its efficacy and mechanism in cerebral ischemia remain unclear, particularly regarding its effect on glutamate...
Saved in:
Main Authors: | Xiaoyu Zheng (Author), Hongwei Zhang (Author), Yehao Zhang (Author), Zhao Ding (Author), Zishan Huang (Author), Haoran Li (Author), Mingjiang Yao (Author), Wenting Song (Author), Jianxun Liu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the pharmacological mechanism of Tongluo Qingnao formula in treating acute ischemic stroke: A combined approach of network pharmacology, molecular docking and experimental evidences
by: Feng Li, et al.
Published: (2024) -
Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke
by: Yehao Zhang, et al.
Published: (2018) -
A Review of Neuroprotective Effects and Mechanisms of Ginsenosides From Panax Ginseng in Treating Ischemic Stroke
by: Aimei Zhao, et al.
Published: (2022) -
Preclinical anti-apoptotic properties of salidroside for hypoxic-ischemic cerebral damage: a systematic review and meta-analysis
by: Wang Xiaobo, et al.
Published: (2023) -
Astrocytic-neuronal-astrocytic Pathway Selection for Formation and Degradation of Glutamate/GABA
by: Tiago B. Rodrigues
Published: (2014)